Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.
about
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Liposomal amphotericin B in th ...... in immunocompromised patients.
@en
Liposomal amphotericin B in th ...... in immunocompromised patients.
@nl
type
label
Liposomal amphotericin B in th ...... in immunocompromised patients.
@en
Liposomal amphotericin B in th ...... in immunocompromised patients.
@nl
prefLabel
Liposomal amphotericin B in th ...... in immunocompromised patients.
@en
Liposomal amphotericin B in th ...... in immunocompromised patients.
@nl
P2093
P2860
P1476
Liposomal amphotericin B in th ...... in immunocompromised patients.
@en
P2093
F Morabito
N Vianelli
P2860
P304
P356
10.1111/J.1399-3062.2010.00519.X
P577
2010-10-01T00:00:00Z